milrinone has been researched along with 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jacobsohn, E; Löwe, H | 1 |
| Muschick, P; Rohde, E; Wiesner, B | 1 |
2 other study(ies) available for milrinone and 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine
| Article | Year |
|---|---|
Protection of the hypoxic myocardium by the bispyridine derivatives AWD 122-14 and milrinone: studies on isolated, working right rabbit hearts.
Topics: Animals; Heart Rate; In Vitro Techniques; Milrinone; Morpholines; Myocardial Contraction; Myocardial Reperfusion Injury; Myocardium; Pyridines; Pyridones; Rabbits; Vasodilator Agents | 1992 |
Hemodynamic response and effects on myocardial energetics of 3-cyano-2-morpholino-5-(pyrid-4-yl)pyridine (AWD 122-14) in anesthetized minipigs.
Topics: Amrinone; Anesthesia; Animals; Calcium Channel Blockers; Cardiotonic Agents; Dopamine; Energy Metabolism; Hemodynamics; Male; Milrinone; Morpholines; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridines; Pyridones; Swine; Swine, Miniature | 1993 |